TQC3927 clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2024
How each study uses TQC3927 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- TQC3927 powder for inhalation
- 2
Studies by the year they started
3 studies that test it; most in 2024 (1)
| Year | Studies |
|---|---|
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 0
Studies
Open first, then newest update. How each study uses TQC3927 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- A Clinical Trial Comparing TQC3927 Inhaled Powder With Glycopyrronium Bromide and Formoterol Inhaled Aerosol (Biovoping® Lingchang®) for the Treatment of Chronic Obstructive Pulmonary DiseaseSuspendedPhase 2Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT07633314Written as TQC3927 inhalation aerosol
- A Clinical Trial of TQC3927 Powder for Inhalation in Chronic Obstructive Pulmonary DiseaseCompletedPhase 1Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT06711991Written as TQC3927 powder for inhalation
- A Study of TQC3927 Powder for Inhalation in Healthy Adult SubjectsCompletedPhase 1Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT06408285Written as TQC3927 powder for inhalation